TAZ antibody (Internal Region)

Catalog No. ABIN7224612

The Rabbit Polyclonal anti-TAZ antibody has been validated for WB and ELISA. It is suitable to detect TAZ in samples from Human.

Quick Overview for TAZ antibody (Internal Region) (ABIN7224612)

Target: TAZ (Tafazzin (TAZ))

Reactivity: Human

Host: Rabbit

Clonality: Polyclonal

Conjugate: This TAZ antibody is un-conjugated

Application: Western Blotting (WB), ELISA

Product Details anti-TAZ Antibody

Binding Specificity: Internal Region

Purpose: Tafazzin Polyclonal Antibody

Specificity: Tafazzin Polyclonal Antibody detects endogenous levels of Tafazzin protein.

Purification: The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen

Immunogen: Synthesized peptide derived from the Internal region of human Tafazzin

Isotype: IgG

Application Details

Application Notes: Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB (1:500-1:2000), ELISA (1:5000). Not yet tested in other applications.

Comment:

Primary Antibody

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: PBS containing 50 % Glycerol, 0.5 % BSA and 0.02 % Sodium Azide.

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: -20 °C

Storage Comment: Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.

Target Details for TAZ

Target: TAZ (Tafazzin (TAZ))

Alternative Name: Tafazzin

Background: Rabbit Anti-Tafazzin Polyclonal Antibody,TAZ, EFE2, G4.5, Tafazzin, Protein G4.5,TAZ (tafazzin) encodes a protein that is expressed at high levels in cardiac and skeletal muscle. Mutations in TAZ have been associated with a number of clinical disorders including Barth syndrome, dilated cardiomyopathy (DCM), hypertrophic DCM, endocardial fibroelastosis, and left ventricular noncompaction (LVNC). Multiple transcript variants encoding different isoforms have been described. A long form and a short form of each of these isoforms is produced, the short form lacks a hydrophobic leader sequence and may exist as a cytoplasmic protein rather than being membrane-bound. Other alternatively spliced transcripts have been described but the full-length nature of all these transcripts is not known.,Tafazzin

Molecular Weight: observerd band 33kDa

Gene ID: 6901

UniProt: Q16635